Try
ICU MEDICAL INC/DE
ICUIUnited States
94 filed reports · 834 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
94 reports · Mar 2013 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 192 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 41 | 9,968 | Mar 2013 to Jun 2026 |
| Current · 8-KSEC EDGAR | 40 | 180 | Mar 2013 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 13 | 7,474 | Dec 2013 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 633 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 6 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 333 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 19, 2026 | 1,285 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 19, 2026 | 6 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 479 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 6 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 251 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 4 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 312 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Feb 27, 2025 | 4 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 27, 2025 | 735 | Open |
Financial data
834 concepts · 17,622 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial818 concepts · 16,578 facts · Sep 2011 to Jul 2026
- Capital expenditures incurred but not yet paid73 · Dec 2011 to Jun 2026
- Depreciation depletion and amortization73 · Dec 2011 to Jun 2026
- Gain loss on sale of property plant equipment73 · Dec 2011 to Jun 2026
- Gross profit (US GAAP)73 · Dec 2011 to Jun 2026
- Income taxes, including excess tax benefits and deferred income taxes73 · Dec 2011 to Jun 2026
- Income tax expense benefit73 · Dec 2011 to Jun 2026
- Increase decrease in accounts payable73 · Dec 2011 to Jun 2026
- Increase decrease in accounts receivable73 · Dec 2011 to Jun 2026
- Increase decrease in accrued liabilities73 · Dec 2011 to Jun 2026
- Increase decrease in inventories73 · Dec 2011 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets73 · Dec 2011 to Jun 2026
- Net cash provided by used in financing activities73 · Dec 2011 to Jun 2026
- Net cash provided by used in investing activities73 · Dec 2011 to Jun 2026
- Net cash provided by used in operating activities73 · Dec 2011 to Jun 2026
- Net income loss73 · Dec 2011 to Jun 2026
- Nonoperating income expense73 · Dec 2011 to Jun 2026
- Operating expenses (US GAAP)73 · Dec 2011 to Jun 2026
- Operating income loss73 · Dec 2011 to Jun 2026
- Payments to acquire intangible assets73 · Dec 2011 to Jun 2026
- Payments to acquire property plant and equipment73 · Dec 2011 to Jun 2026
- Proceeds from stock options exercised73 · Dec 2011 to Jun 2026
- Research and development expense73 · Dec 2011 to Jun 2026
- Revenue73 · Dec 2011 to Jun 2026
- Selling general and administrative expense73 · Dec 2011 to Jun 2026
Product5 concepts · 581 facts · Dec 2011 to Jun 2026
- Revenue266 · Dec 2011 to Jun 2026
- Increase decrease in deferred revenue132 · Mar 2018 to Jun 2026
- Deferred revenue additions123 · Mar 2018 to Jun 2026
- Infusion Consumables45 · Dec 2016 to Dec 2025
- UNITED STATES15 · Dec 2015 to Dec 2017
Geography4 concepts · 281 facts · Dec 2012 to Jun 2026
- Revenue245 · Dec 2015 to Jun 2026
- UNITED STATES32 · Dec 2012 to Dec 2025
- Effective income tax rate reconciliation foreign income tax rate differential2 · Dec 2025
- Income tax reconciliation foreign income tax rate differential2 · Dec 2025
Guidance7 concepts · 182 facts · Apr 2013 to Aug 2026
- EPS (Diluted) Guidance82 · Apr 2013 to Aug 2026
- Net Income Guidance40 · Feb 2016 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))28 · Feb 2014 to Aug 2026
- Revenue Guidance26 · Apr 2013 to Mar 2017
- Capital Expenditures Guidance2 · Aug 2026
- Effective Tax Rate Guidance2 · Feb 2014
- Gross Margin Guidance2 · Feb 2014
Segments
862 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis14 members · 515 facts
- Equipmentrevenue84 · Mar 2018 to Jun 2026
- Softwarerevenue84 · Mar 2018 to Jun 2026
- Infusion Consumables56 · Dec 2016 to Jun 2026
- Infusion Systems56 · Dec 2016 to Jun 2026
- Other Deferred Revenue44 · Mar 2022 to Jun 2026
- Critical Care36 · Dec 2016 to Dec 2022
- IV Solutions36 · Dec 2016 to Dec 2022
- Government Grant Revenue35 · Mar 2022 to Jun 2026
- Vital Care33 · Dec 2020 to Jun 2026
- Infusion Consumables Smiths Medical12 · Dec 2020 to Dec 2022
- Other Revenue12 · Dec 2016 to Dec 2019
- Vascular Access12 · Dec 2020 to Dec 2022
- Product8 · Dec 2016 to Dec 2019
- Product And Service Other7 · Dec 2016 to Dec 2019
Statement geographicalsrt:StatementGeographicalAxis13 members · 219 facts
- US56 · Dec 2016 to Jun 2026
- EMEA46 · Dec 2016 to Jun 2026
- Otherforeigncountries44 · Dec 2016 to Jun 2026
- Foreign26 · Dec 2016 to Jun 2022
- Asia Pacific17 · Sep 2017 to Jun 2026
- International Sales Domain10 · Dec 2016 to Dec 2025
- APAC Domain6 · Dec 2020 to Dec 2025
- Latin America4 · Sep 2017 to Sep 2022
- Americas2 · Sep 2021 to Sep 2022
- CA2 · Sep 2021 to Sep 2022
- CR2 · Dec 2025
- Foreign Tax Jurisdiction Other2 · Dec 2025
- North America2 · Sep 2017 to Sep 2018
Product or serviceus-gaap:ProductOrServiceAxis11 members · 66 facts
- Other Revenue12 · Dec 2011 to Jun 2018
- Critical Care7 · Dec 2015 to Jun 2018
- Infusion Consumables7 · Dec 2015 to Jun 2018
- Infusion Systems7 · Dec 2015 to Jun 2018
- IV Solutions7 · Dec 2015 to Jun 2018
- Critical Care Revenue5 · Dec 2011 to Dec 2015
- Infusion Therapy5 · Dec 2011 to Dec 2015
- Oncology Revenue5 · Dec 2011 to Dec 2015
- Equipmentrevenue4 · Mar 2018 to Jun 2018
- Softwarerevenue4 · Mar 2018 to Jun 2018
- Sales Revenue Net3 · Dec 2013 to Dec 2015
Statement geographicalus-gaap:StatementGeographicalAxis12 members · 62 facts
- US13 · Dec 2012 to Jun 2018
- Asia Pacific7 · Dec 2015 to Jun 2018
- Foreign7 · Dec 2015 to Jun 2018
- Otherforeigncountries7 · Dec 2015 to Jun 2018
- International Sales Domain6 · Dec 2012 to Dec 2017
- EMEA4 · Mar 2017 to Jun 2018
- Latin America4 · Mar 2017 to Jun 2018
- North America4 · Mar 2017 to Jun 2018
- CA3 · Dec 2015 to Dec 2017
- Europe3 · Dec 2015 to Dec 2017
- Other LATAM3 · Dec 2015 to Dec 2017
- Otherforeigncountries1 · Dec 2020
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.